Molecule Details
| InChIKey | QWIZYRGWEQXHJG-HHHXNRCGSA-N |
|---|---|
| Compound Name | 1-[4-[(2R)-6-bromo-15-methoxy-13-methyl-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone |
| Canonical SMILES | COc1cc(C)cc2c1[C@@H](C1CCN(C(=O)Cc3cc[n+]([O-])cc3)CC1)c1ncc(Br)cc1CC2 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.44 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile